HCV Disease Progression
Liver Cancer Increasing among People with HIV/HCV Coinfection
- Details
- Category: Liver Cancer/HCC
- Published on Friday, 15 February 2013 00:00
- Written by Liz Highleyman
Hepatocellular carcinoma (HCC) is a growing problem among HIV positive people coinfected with hepatitis C virus (HCV) in Spain, and it is often diagnosed at a late stage when it is difficult to treat, researchers reported in the January 1, 2013, issue of Clinical Infectious Diseases.
Hepatitis C Re-treatment with Interferon Monotherapy Provides Little Benefit
- Details
- Category: HCV Treatment
- Published on Wednesday, 06 February 2013 00:00
- Written by Liz Highleyman
Long-term re-treatment with pegylated interferon monotherapy offers little or no clinical benefit -- even though it may suppress hepatitis C virus (HCV) levels and improve liver fibrosis -- but it can cause adverse events and may be associated with higher mortality, according to a systematic review from the Cochrane Library.
Hepatitis C Cirrhosis Patients with Sustained Treatment Response Have Lower Risk of Death
- Details
- Category: HCV Treatment
- Published on Thursday, 27 December 2012 00:00
- Written by Liz Highleyman
Hepatitis C patients with cirrhosis who achieve sustained virological response to interferon-based therapy have a reduced risk of all-cause mortality, liver-related death or transplantation, liver cancer, and liver failure compared with non-responders, according to a study described in the December 26, 2012, issue of JAMA.
HIV+ People Who Get Hepatitis C May Experience Rapid Liver Disease Progression
- Details
- Category: HCV Sexual Transmission
- Published on Tuesday, 08 January 2013 00:00
- Written by Liz Highleyman
People with HIV, especially those with advanced immune suppression, who become coinfected with hepatitis C virus (HCV) may experience rapid progression to decompensated cirrhosis and liver-related death, Mt. Sinai researchers reported in the December 21, 2012, advance edition of Clinical Infectious Diseases.
Coverage of the 2012 AASLD Liver Meeting
- Details
- Category: HBV Treatment
- Published on Tuesday, 13 November 2012 00:00
- Written by Liz Highleyman
HIVandHepatitis.com coverage of the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2012) in Boston, November 9-13, 2012.
Conference highlights include treatment for hepatitis B and C, new direct-acting HCV drugs, interferon-free hepatitis C therapy, management of liver disease complications, HIV/HBV and HIV/HCV coinfection, and prevention and treatment of hepatocellular carcioma.
HIVandHepatitis.com AASLD 2012 conference section
More Articles...
- Hepatitis C Raises Risk of Both Liver-Related and Non-Liver Deaths
- FibroScan Liver Stiffness Measurement Predicts Liver Failure and Death
- Insulin Resistance Linked to Liver Disease Progression in HIV/HCV Coinfected Patients
- Hepatitis C Treatment Reduces HIV Progression and Death in HIV/HCV Coinfected
Web Design and Development by